Neuropathic Orofacial Pain: Proposed Mechanisms, Diagnosis, and Treatment Considerations

Dental Clinics of North America

Volumn 51, Issue 1, 2007, Pages 209-224

  Spencer, Christopher J ^a   Gremillion, Henry A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FACE PAIN; HUMAN; NEURALGIA; PATHOPHYSIOLOGY; POSTHERPETIC NEURALGIA; REVIEW; TRIGEMINUS NEURALGIA; VIROLOGY;

FACIAL PAIN; HUMANS; NEURALGIA; NEURALGIA, POSTHERPETIC; TRIGEMINAL NEURALGIA;

EID: 33845493861     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2006.09.006     Document Type: Review

References (62)

1. Donaldson D., and Kroening R. Recognition and treatment of patients with chronic orofacial pain. J Am Dent Assoc 99 (1979) 961-966
2. Lipton J.A., Ship J.A., and Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc 124 (1993) 115-121
3. Merskey H., and Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd edition (1994), IASP Press, Seattle (WA)
4. Rowbotham M., Harden N., Stacey B., et al., for the Gabapentin Postherpetic Neuralgia Study Group. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280 (1998) 1837-1842
5. Rice A.S.C., Maton S., and for the Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomized, double blind study. Pain 94 (2001) 215-224
6. Osterberg A., Boivie J., Holmgren H., et al. The clinical characteristics and sensory abnormalities of patients with central pain caused by multiple sclerosis. In: Gebhart G.F., Hammond D.L., and Jensen T.S. (Eds). Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management, vol. 2 (1994), IASP Press, Seattle (WA) 789-796
7. Hansson P. Neurogenic pain. Pain Clin Updates II (1994) 1-4
8. Koltzenburg M., Torebjork H.E., and Wahren L.K. Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain. Brain 117 (1994) 579-591
9. Marbach J.J., Hulbrock J., Hohn C., et al. Incidence of phantom tooth pain: an atypical facial neuralgia. Oral Surg Oral Med Oral Pathol 53 (1982) 190-193
10. Campbell R.L., Parks K.W., and Dodds R.N. Chronic facial pain associated with endodontic therapy. Oral Surg Oral Med Oral Pathol 69 (1990) 287-290
11. Westrum L.E., Canfield R.C., and Black R.G. Transganglionic degeneration in the spinal trigeminal nucleus following removal of tooth pulps in adult cats. Brain Res 101 (1976) 137-140
12. Keller O., Kalina M., Juec E., et al. Projection of tooth pulp afferents to the brainstem and to the cortex in the cat. Neurosci Lett 25 (1981) 233-237
13. Devor M. Sodium channels and mechanisms of neuropathic pain. J Pain 7 Suppl 1 (2006) s3-s12
14. Priestley T. Voltage-gated sodium channels and pain. Curr Drug Targets CNS Neurol Disord 3 (2004) 441-456
15. Liu C.-N., Michaelis M., Amir R., and Devor M. Spinal nerve injury enhances subthreshold membrane potential oscillations in DRG neurons: relation to neuropathic pain. J Neurophysiol 84 (2000) 205-215
16. Wu G., Ringkamp M., Murinson B.B., et al. Degeneration of myelinated efferent fibers induces spontaneous activity in uninjured C-fiber afferents. J Neurosci 22 (2002) 7746-7753
17. Wood J.N., Abrahamsen B., Baker M.D., et al. Ion channel activities implicated in pathological pain. Novartis Found Symp 261 (2004) 32-40 [discussion: 40-54]
18. Takahashi N., Nikuchi S., Dai Y., et al. Expression of auxiliary beta subunits of sodium channels in primary afferent neurons and effect of nerve injury. Neuroscience 121 (2003) 441-450
19. Chung J.M., Dib-Hajj S.D., and Lawson S.N. Sodium channel sub-types and neuropathic pain. In: Dostrovsky J.O., Carr D.B., and Koltzenburg M. (Eds). Proceedings of the 10th World Congress of Pain, Progress in Pain Research and Management, vol. 24 (2003), IASP Press, Seattle (WA) 99-114
20. Chahine M., Ziane R., Vijayvaragavan K., et al. Regulation of Na v channels in sensory neurons. Trends Pharmacol Sci 26 (2005) 496-502
21. Kretschmer T., Happel L.T., England J.D., et al. Accumulation of PN1 an PN3 sodium channels in painful human neuroma-evidence from immunocytochemistry. Acta Neurochir (Wien) 144 (2002) 803-810
22. Craner M.J., Lo A.C., Black J.A., et al. Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination. Brain 126 (2003) 1552-1561
23. + channels and node of Ranvier formation in remyelinating axons. J Neurosci 15 (1995) 492-503
24. Stacey B.R. Management of peripheral neuropathic pain. Am J Phys Med Rehabil 84 Suppl (2005) S4-S16
25. McQuay M., and Moore A. An evidence-based resource for pain relief (1998), Oxford University Press, Oxford
26. Takatori M., Kuroda Y., and Hirose M. Local anesthetics suppress nerve growth factor-mediated neurite outgrowth by inhibition of tyrosine kinase activity of TrkA. Anesth Analg 102 (2006) 462-467
27. Woolf C.J., and Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 23 (1985) 361-374
28. Sawynok J. Topical analgesics in neuropathic pain. Curr Pharm Des 11 (2005) 2995-3004
29. Dressler R.L. Systemic lidocaine or mexiletine for neuropathic pain. American Family Physician Cochrane for Clinicians 74 (2006) 4-5
30. Carneado-Ruiz J., Morera-Guitart J., Alfaro-Saez A., et al. Neuropathic pain as the reason for visiting neurology: an analysis of its frequency. Rev Neurol 41 (2005) 643-648 [comment: 641-2]
31. Brewis M., Poskanzer D.C., Rolland C., et al. Neurological disease in an English city. Acta Neurol Scand 42 Suppl 24 (1966) 1-89
32. Hall G.C., Carroll D., Parry D., et al. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 122 (2006) 156-162
33. Sicuteri F., Nicolodi M., Fusco B.M., et al. Idiopathic headache as a possible risk factor for phantom tooth pain. Headache 31 (1991) 577-581
34. Rozen T.D. Trigeminal neuralgia and glossopharyneal neuralgia. Neurol Clin N Am 22 (2004) 185-206
35. Fromm G.H. Pathophysiology of trigeminal neuralgia. In: Fromm G.H., and Sessle B.J. (Eds). Trigeminal neuralgia: current concepts regarding pathogenesis and treatment (1991), Butterworth-Heinemann, Boston 105-130
36. Neto H.S., Camilli J.A., and Marques M.J. Trigeminal neuralgia caused by maxillary and mandibular nerve entrapment: greater incidence of right sided facial symptoms is due to the foremen rotundum and foremen ovale being narrower on the right side of the cranium. Med Hupotheses 65 (2005) 1179-1182
37. Hamlyn P.J., and King T.T. Neurovascular compression in trigeminal neuralgia: a clinical and anatomical study. J Neurosurg 76 (1992) 948-954
38. Barker G.G., Janetta P.J., Bissonette D.J., et al. The long term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med 334 (1996) 1077-1083
39. Lopez B.C., Hamlyn P.J., and Zakrzewska J.M. Systematic review of ablative neurosurgical techniques for the treatment of trigeminal neuralgia. Neurosurg 54 4 (2004) 973-982
40. Onofrio B.M. Radiofrequency percutaneous gasserian ganglion lesions: results in 140 patients with trigeminal pain. J Neurosurg 42 (1975) 132-139
41. Arias M.J. Percutaneous retrogasserian glycerol rhizotomies for trigeminal neuralgia: a prospective study of 100 cases. Neurosurgery 65 (2000) 32-36
42. Panula K., Finne K., and Oikarinen K. Incidence of complications and problems related to orthognathic surgery: a review of 655 patients. J Oral Maxillofac Surg 59 (2001) 1128-1136
43. Carmichael F.A., and McGowan D.A. Incidence of nerve damage following third molar removal: a West of Scotland Oral Surgery Research Group study. Br J Oral Maxillofac Surg 30 (1992) 78-82
44. Koltzenburg M., and Bendszus M. Imaging of peripheral nerve lesions. Curr Opin Neurol 17 (2004) 621-626
45. Robinson P.P., Boissonade F.M., Loescher A.R., et al. Peripheral mechanisms for the initiation of pain following trigeminal nerve injury. J Orofac Pain 18 (2004) 287-292
46. Graff-Radford S.B., and Solberg W.K. Atypical odontalgia. Craniomandibular Disord 6 (1992) 260-265
47. Graff-Radford S.B., and Solberg W.K. Is atypical odontalgia a psychological problem?. Oral Surg Oral Med Oral Pathol 75 (1993) 579-582
48. Jensen J.L., and Barr R.J. Lesions of the facial skin. In: Wood N.K., and Goaz P.W. (Eds). Differential diagnosis of oral and maxillofacial lesions. 5th edition (1997), Mosby, St. Louis (MO) 557-558
49. Kennedy P.G. Varicella-Zoster virus latency in human ganglia. Rev Med Virol 12 (2002) 327-334
50. Stankus S.J., Diugopolski M., and Packer D. Management of herpes zoster (shingles) and post-herpetic neuralgia. Am Fam Phys 61 (2000) 2437-2448
51. Gnann J.W., and Whitley R.J. Herpes zoster. N Engl J Med 347 5 (2002) 340-346
52. Sumpf M.P., Laidlaw Z., and Jansen V.A. Herpes viruses hedge their bets. Proc Natl Acad Sci 99 23 (2002) 15234-15237
53. Madison L.K. Shingles update: common questions in caring for a patient with shingles. Orthop Nurs 19 1 (2000) 59-62
54. Dugan L.L., and Choi D.W. Excitotoxicity, free radicals and cell membrane changes. Ann Neurol suppl (1994) 517-521
55. Goh C.L., and Khoo L. A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology referral clinic. Int J Dermatol 36 (1997) 667-672
56. Rowbotham M.C., and Fields H.L. The relationship of pain, allodynia, and thermal sensation in post-herpetic neuralgia. Brain 119 (1996) 347-354
57. Fleetwood-Walker S.M., Quinn J.P., Wallace C., et al. Behavior changes in the rat following infection with varicella-zoster virus. J Gen Virol 80 (2002) 2433-2436
58. Bowsher D. Post-herpetic neuralgia in older patients, incidence, and optimal treatment. Drugs Aging 5 (1994) 411-418
59. Bryson H.M., and Wilde M.I. Amitriptyline: a review of it's pharmacological properties and therapeutic use in chronic pain states. Drugs Aging 8 (1996) 459-476
60. Scheinfeld N. The role of gabapentin in treating diseases with cutaneous manifestations and pain. Int J Dermatol 42 (2003) 491-495
61. Ahmad M., and Goucke C.R. Management strategies for the treatment of neuropathic pain in the elderly. Drugs Aging 19 (2002) 929-945
62. Campbell B.J., Rowbotham M., Davies P.S., et al. Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. J Pharm Sci 9 (2002) 1343-1350